- Home
- PCVX vs VNO Comparison
PCVX vs VNO Comparison
Compare PCVX & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | VNO |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | 3145 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | VNO |
|---|---|---|
| Price | $54.07 | $39.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | ★ $88.25 | $33.00 |
| AVG Volume (30 Days) | 991.2K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.42 |
| P/E Ratio | ★ N/A | $7.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.10 | $24.57 |
| 52 Week High | $65.00 | $43.37 |
Technical Indicators
Market Signals| Indicator | PCVX | VNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 57.39 |
| Support Level | $52.04 | $37.94 |
| Resistance Level | $56.04 | $41.12 |
| Average True Range (ATR) | 2.24 | 1.21 |
| MACD | -0.37 | -0.09 |
| Stochastic Oscillator | 53.19 | 56.89 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About VNO Vornado Realty Trust
Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.